Ranbaxy and AstraZeneca Reach Agreement
Selected Abstract
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation.
Companies Also Sign Manufacturing and Distribution Agreement GURGAON, India and PRINCETON, N.J., April 15 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has reached several agreements with AstraZeneca. Two ...
April 15, 2008; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation.
|